| Naziv |
Akcije |
| Milunović, Vibor; Mandac Smoljanović, Inga; Bogeljić Patekar, Martina; Zatezalo, Viktor; Kursar, Marin; Radić-Krišto, Delfa; Ostojić Kolonić, Slobodanka; Gašparov, Slavko
First-line therapy for nodal T-cell non-Hodgkin lymphomas: an unmet need in hematology // Current Oncology Reports, 25 (2023), 813-824. doi: 10.1007/s11912-023-01400-w |
|
| Galušić, Davor ; Bašić-Kinda, Sandra ; Pijuk, Anđela ; Milunović, Vibor ; Dreta, Barbara ; Franjić, Neven ; Coha, Božena ; Sinčić-Petričević, Jasminka ; Gaćina, Petar ; Pejša, Vlatko et al.
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6. doi: 10.1097/HS9.0000000000000807 |
|
| Vibor Milunović, Ida Hude, Goran Rinčić, Davor Galušić, Aron Grubešić, Marko Martinović, Nika Popović, Sunčana Divošević, Klara Brčić, Marin Međugorac, Luka Kužat, Dejan Strahija, Stefan Mrđenović, Inga Mandac Smoljanović, Delfa Radić- Krišto, Slavko Gašparov, Igor Aurer, Slobodanka Ostojić Kolonić
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma // Biomedicines, 10 (2022), 1-22. doi: 10.3390/biomedicines10112917. |
|
| Milunović, Vibor ; Hude, Ida ; Rinčić, Goran ; Galušić, Davor ; Grubešić, Aron ; Martinović, Marko ; Popović, Nika ; Divošević, Sunčana ; Brčić, Klara ; Međugorac, Marin et al.
Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review // Biomedicines, 10 (2022), 11; 2917, 22. doi: 10.3390/biomedicines10112917 |
|
| Aurer, Igor ; Jakšić, Ozren ; Basic-Kinda, Sandra ; Mišura Jakobac, Karla ; Sinčić-Petričević, Jasminka ; Novaković Coha, Sabina ; Galušić, Davor ; Holik, Hrvoje ; Valković, Toni ; Županić-Krmek, Dubravka et al.
Feasibility of obinutuzumab (G) combined with higher doses of chlorambucil (Clb) for frontline treatment of CLL: a retrospective non-interventional study of KroHem, the Croatian Cooperative Group for Hematologic Diseases // Leukemia & lymphoma. 2020. str. 111-112 doi: 10.1080/10428194.2020.1732667 |
|
| Milunović, Vibor ; Mišura Jakobac, Karla ; Mandac Rogulj, Inga ; Martinović, Marko ; Radić-Krišto, Delfa ; Ostojić Kolonić, Slobodanka
The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia – are we ready for chemo-free immunotherapy approach? // Expert review of hematology, 13 (2020), 7; 771-779. doi: 10.1080/17474086.2020.1775575 |
|
| Aurer, Igor ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Mišura Jakobac, Karla ; Sinčić- Petričević, Jasminka ; Novaković Coha, Sabina ; Galušić, Davor ; Holik, Hrvoje ; Valković, Toni ; Županić-Krmek, Dubravka et al.
Podnošljivost kombinacija obinutuzumaba i viših doza klorambucila u prvoj liniji liječenja kronične limfocitne leukemije // Bilten Krohema, 12 (2020), 1; 23-23 |
|
| Milunović, Vibor ; Žalac, Klara ; Brcić, Hrvoje ; Zimak, Romyna ; Mišura Jakobac, Karla ; Mandac Rogulj, Inga ; Kursar, Marin ; Martinović, Marko ; Radić Krišto, Delfa ; Ostojić Kolonić, Slobodanka
Determinants of quality of life in multiple myeloma patients: Croatian experience // HemaSphere. 2020. str. 809-810 doi: 10.1097/HS9.0000000000000404 |
|
| Mandac Rogulj, Inga ; Kardum Paro, Mirjana Mariana ; Milunović, Vibor ; Mišura Jakobac, Karla ; Zatezalo, Viktor ; Aćamović Stipinović, Bojana ; Bogeljić Patekar, Martina ; Kursar, Marin ; Martinović, Marko ; Rinčić, Goran et al.
MICRORNA 99B and LET7A as diagnostic parameters in myelodysplastic syndrome // HemaSphere. 2020. str. 899-899 doi: 10.1097/HS9.0000000000000404 |
|
| Milunović, Vibor ; Mišura Jakobac, Karla ; Kursar, Marin ; Mandac Rogulj, Inga ; Ostojić Kolonić, Slobodanka
FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town? // European journal of haematology, 103 (2019), 3; 145-151. doi: 10.1111/ejh.13269 |
|
